Effect of β-cryptoxanthin plus phytosterols on cardiovascular risk and bone turnover markers in post-menopausal women: A randomized crossover trial

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 10, 2014, Pages 1090-1096

  Granado Lorencio, F ^a   Lagarda, M J ^b   Garcia Lopez F J ^c   Sanchez Siles L M ^d   Blanco Navarro, I ^a   Alegria A ^b   Perez Sacristan B ^a   Garcia Llatas, G ^b   Donoso Navarro, E ^a   Silvestre Mardomingo, R A ^a   Barbera R ^b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

^d Global Technology Centre for Infant Nutrition   (Spain)

Author keywords

Bone turnover; Cardiovascular risk; Phytosterols; Post menopausal women; Cryptoxanthin

Indexed keywords

BETA CRYPTOXANTHIN; CAMPESTEROL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; PHYTOSTEROL; SITOSTEROL; STIGMASTEROL; CRYPTOXANTHIN; GAMMA-SITOSTEROL; SITOSTEROL DERIVATIVE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD ANALYSIS; BONE TURNOVER; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; MIDDLE AGED; NORMAL HUMAN; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; AGED; ANALOGS AND DERIVATIVES; BLOOD; BONE; CARDIOVASCULAR DISEASES; DOSE RESPONSE; DRUG EFFECTS; HYPERCHOLESTEROLEMIA; INTERVENTION STUDY; METABOLISM; ORAL DRUG ADMINISTRATION; RISK FACTOR;

ADMINISTRATION, ORAL; AGED; BONE AND BONES; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; CRYPTOXANTHINS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HEALTHY VOLUNTEERS; HUMANS; HYPERCHOLESTEROLEMIA; INTERVENTION STUDIES; MIDDLE AGED; PHYTOSTEROLS; POSTMENOPAUSE; RISK FACTORS; SITOSTEROLS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84908406679     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2014.04.013     Document Type: Article

References (30)

1. WHO/FAO Expert Consultation Diet, nutrition and the prevention of chronic diseases. WHO Technical Report Series 916 2003, WHO, Geneva.
2. Jochem C., Islander U., Erlandson M., Verdrengh C., Ohlsson C., Carlsten H. Osteoporosis in experimental postmenopausal polyarthritis: relative contributions of estrogen deficiency and inflammation. Arthritis Res Ther 2005, 7:837-843.
3. Prentice A. Diet, nutrition and the prevention of osteoporosis. Public Health Nutr 2004, 7:227-243.
4. Yamaguchi M. β-Cryptoxanthin and bone metabolism: the preventive role in osteoporosis. J Health Sci 2008, 54:356-369.
5. Sahni S., Hannan M.T., Blumberg J., Cupples L.A., Kiedel D.P., Tucker K.L. Inverse association of carotenoid intakes with 4-y change in bone mineral density in elderly men and women: the Framingham Osteoporosis Study. Am J Clin Nutr 2009, 89:416-424.
6. Sugiura M., Nakamura M., Ogawa K., Ikoma Y., Ando F., Shimokata H., et al. Dietary patterns of antioxidant vitamin and carotenoid intake associated with bone mineral density; findings from post-menopausal Japanese female subjects. Osteoporos Int 2011, 22:143-152.
7. Cerhan J., Saag K.G., Merlino L.A., Mikuls T.R., Criswell L.A. Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women. Am J Epidemiol 2003, 157:345-354.
8. Maggio D., Polidori M.C., Barabani M., Tufi A., Ruggiero C., Cecchetti R., et al. Low levels of carotenoids and retinol in involutional osteoporosis. Bone 2006, 38:244-248.
9. Yamaguchi M., Uchiyama S. β-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture invitro. Mol Cell Biochem 2004, 258:137-144.
10. Yamaguchi M., Igarashi A., Uchiyama S., Morita S., Sugawara K., Sumida T. Prolonged intake of juice (Citrus unshiu) reinforced with β-cryptoxanthin has an effect on circulating bone biochemical markers in normal individuals. J Health Sci 2004, 50:619-624.
11. Nelson E.R., Wardell S.E., McDonnell D.P. The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols; implications for the treatment and prevention of osteoporosis. Bone 2013, 53:42-50.
12. Gylling H., Plat J., Turley S., Ginsberg H.N., Ellegård L., Jessup W., et al. Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease. Atherosclerosis 2014, 232:346-360.
13. Marangoni F., Poli A. Phytosterols and cardiovascular health. Pharmacol Res 2010, 61:193-199.
14. Ras R.T., Hiemstra H., Lin Y., Vermeer M.A., Duchateau G.S.M.J.E., Trautwein L.A. Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations - a meta-analysis of randomized controlled studies. Atherosclerosis 2013, 230:3336-3346.
15. Weingartner O., Baber R., Teupser D. Plant sterols in foods: no consensus in guidelines. Biochem Biophys Res Commun 2014, http://dx.doi.org/10.1016/j.bbrc.2014.01.147.
16. Granado-Lorencio F., Donoso-Navarro E., Sanchez-Siles L.M., Blanco-Navarro I., Pérez-Sacristán B. Invitro and invivo bioavailability of β-cryptoxanthin in the presence of phytosterols. J Agric Food Chem 2011, 59:11819-11824.
17. González-Larena M., Cilla A., García-Llatas G., Barberá R., Lagarda M.J. Plant sterols and antioxidant parameters in enriched beverages: storage stability. J Agric Food Chem 2012, 60:4725-4734.
18. Alemany L., Cilla A., García-Llatas G., Rodriguez-Estrada M.T., Cardenia V., Alegria A. Effect of simulated gastrointestinal digestion on plant sterols and their oxides in enriched beverages. Food Res Int 2013, 52:1-7.
19. Granado-Lorencio F., Herrero-Barbudo C., Blanco-Navarro I., PérezSacristán B. Suitability of ultra-performance liquid chromatography for the determination of fat-soluble nutritional status (vitamin A, E, D and individual carotenoids). Anal Bioanal Chem 2010, 397:1389-1893.
20. García-Llatas G., Vidal C., Cilla A., Barberá R., Lagarda M.J. Simultaneous quantification of serum phytosterols and cholesterol precursors using a simple gas chromatographic method. Eur J Lipid Sci Technol 2012, 114:520-526.
21. Vasikaran S., Eastell R., Bruyère O., Foldes A.J., Garnero P., Griesmacher A., et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int 2011, 22:391-420.
22. Zambón D., Sabaté J., Muñoz S., Campero B., Casals E., Merlos M., et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial. Ann Intern Med 2000, 132:538-546.
23. Rideaout T.C., Harding S.V., Mackay D.S. Metabolic and genetic factors modulating subject specific LDL-C responses to plant sterol therapy. Can J Physiol Pharmacol 2012, 90:509-514.
24. De Jong A., Plat J., Mensink R.O. Metabolic effects of plant sterols and stanols (review). J Nutr Biochem 2003, 14:362-369.
25. Herron K.L., McGrane M.M., Waters D., Lofgren I.E., Clark R.M., Ordovas J.M., et al. The ABCG5 polymorphism contributes to individual responses to dietary cholesterol and carotenoids in eggs. J Nutr 2006, 136:1161-1165.
26. Zhao H.E., Houweling A.H., Vanstone C.A., Jew S., Trautwein E.A., Duchateau G., et al. Genetic variation in ABC G5/G8 and NPC1L1 impact cholesterol response to plant sterols in hypercholesterolemic men. Lipids 2008, 43:1155-1164.
27. Teupser D., Baber R., Ceglarek U., Scholz M., Illig T., Gieger C.H., et al. Genetic regulation of serum phytosterol levels and risk of coronary artery disease. Circ Cardiovasc Genet 2010, 3:331-339.
28. Matsumoto A., Mizukami H., Mizuno S., Umegaki K., Nisikawa J., Shudo K., et al. Beta-Cryptoxanthin, a novel natural RAR ligand, induces ATP-binding cassette transporters in macrophages. Biochem Pharmacol 2007, 74:256-264.
29. Fu H., Wu C., Riaz H., Zhang H., Han J., Bai L., et al. Beta-cryptoxanthin uptake in THP-1 macrophages upregulates the CYP27A1 signaling pathway. Mol Nutr Food Res 2013, 00:1-12.
30. Li T., Chen W., Chiang J.Y.L. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res 2007, 48:373-384.